MARKET

ALPN

ALPN

Alpine Immune
NASDAQ

Real-time Quotes | Nasdaq Last Sale

2.600
-0.120
-4.41%
Closed 16:00 11/15 EST
OPEN
2.341
PREV CLOSE
2.720
HIGH
2.668
LOW
2.330
VOLUME
1.26K
TURNOVER
--
52 WEEK HIGH
8.24
52 WEEK LOW
2.250
MARKET CAP
48.33M
P/E (TTM)
-0.8612
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of ALPN and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 4 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

ALPN News

  • Alpine Immune Sciences EPS beats by $0.06, beats on revenue
  • seekingalpha.2d ago
  • Alpine Immune Sciences, Inc. (ALPN) CEO . Mitchell Gold on Q3 2019 Results - Earnings Call Transcript
  • Seeking Alpha - Transcript.3d ago
  • Alpine Immune Sciences Q3 EPS $(0.62) Beats $(0.68) Estimate, Sales $289K Beat $190K Estimate
  • Benzinga.3d ago
  • Alpine Immune Sciences Provides Corporate Update and Reports Third Quarter 2019 Financial Results
  • Business Wire.3d ago

More

Industry

Biotechnology & Medical Research
+1.25%
Pharmaceuticals & Medical Research
+1.34%

Hot Stocks

Name
Price
%Change

About ALPN

Alpine Immune Sciences, Inc., formerly Nivalis Therapeutics, Inc., is focused on developing a protein-based immunotherapies using Variant immunoglobulin domain (vlgD) platform technology. The vlgD platform is designed to interact with multiple targets, including many present in the immune synapse. The vlgDs are developed using a process known as directed evolution. The vlgD platform exploits both known and unknown interactions at immune synapse through a process called direct evolution for patients living with cancer, autominnue/inflammatory conditions and chronic infectious disease. It optimizes native immune system proteins for use as therapeutics. The Company also developed Transmembrane Immunomodulatory Protien (TIP) technology, based on the vIgD platform, to enhance engineered cellular therapies. TIP program is created to help companies focused on engineered cellular therapies.
More

Webull offers Alpine Immune Sciences Inc (ALPN) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.